XML 101 R58.htm IDEA: XBRL DOCUMENT v3.23.3
Shareholders’ Equity - Schedule of Stock Option Activity (Details)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Number of Shares    
Outstanding at beginning of period (in shares) | shares 10,243,772  
Exercised (in shares) | shares (273,035)  
Forfeited or expired (in shares) | shares (57,142)  
Outstanding at end of period (in shares) | shares 10,549,893 10,243,772
Options vested and exercisable (in shares) | shares 8,877,936  
Weighted Average Exercise Price    
Weighted average exercise price, beginning balance (in usd per share) | $ / shares $ 6.43  
Exercised (in usd per share) | $ / shares 0.95  
Forfeited or expired (in usd per share) | $ / shares 10.61  
Weighted average exercise price, ending balance (in usd per share) | $ / shares 6.28 $ 6.43
Options vested and exercisable (in usd per share) | $ / shares $ 6.34  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]    
Total Intrinsic Value | $ $ 4,659 $ 1,956
Options vested and exercisable, intrinsic value | $ $ 4,246  
Weighted Average Remaining Contractual Life (Years) 5 years 8 months 12 days 6 years
Options vested and exercisable, weighted average remaining contractual term 5 years 8 months 12 days  
Market and service condition based options    
Number of Shares    
Outstanding at beginning of period (in shares) | shares 4,453,297  
Outstanding at end of period (in shares) | shares 4,453,297 4,453,297
Options vested and exercisable (in shares) | shares 3,994,964  
Weighted Average Exercise Price    
Weighted average exercise price, beginning balance (in usd per share) | $ / shares $ 12.75  
Weighted average exercise price, ending balance (in usd per share) | $ / shares 12.75 $ 12.75
Options vested and exercisable (in usd per share) | $ / shares $ 11.96  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]    
Total Intrinsic Value | $ $ 0 $ 0
Options vested and exercisable, intrinsic value | $ $ 0  
Weighted Average Remaining Contractual Life (Years) 3 years 10 months 24 days 4 years 8 months 12 days
Options vested and exercisable, weighted average remaining contractual term 3 years 9 months 18 days